loading
qolac journals logo white

Advertisement

Long-Term Feasibility and Outcomes of a Digital Health Program to Improve Liver Fat and Cardiometabolic Markers in Individuals With Nonalcoholic Fatty Liver Disease: Prospective Single-Arm Feasibility Study
QOLAC Medicine Cover


Full Text
Download PDF/A
ePUB
XML
Visual Abstract

Keywords

Medicine

Categories

How to Cite

Björnsdottir, S., Ulfsdottir, H., & Gudmundsson, E. F. (2025). Long-Term Feasibility and Outcomes of a Digital Health Program to Improve Liver Fat and Cardiometabolic Markers in Individuals With Nonalcoholic Fatty Liver Disease: Prospective Single-Arm Feasibility Study. QOLAC Medicine, 1(1), 3-12. https://doi.org/10.1016/qolacmedicine.v1i01.2

Abstract

Background:

Kidney transplantation has become the treatment of choice for patients with end stage renal disease since it offers an excellent quality of life. Moreover, the economic impact is considerable, particularly beyond the first year.

Methods:

Indeed, the annual cost of a successful renal transplantation is ten fold lower than haemodialysis. But surgical complications remain one of our main concerns. Surgical complications are various. They may be non-specific as haematomas, incision-induced hernias and wound infections.

Results:

They may also be directly related to the procedure as vascular thrombosis and urinary fistula in the early post-operative period or arterial stenosis and ureteral obstruction in the late post-operative period. The accurate diagnosis and the appropriate management of these complications are the most important tasks for the surgical team.

Conclusion:

This review is based upon our experience in kidney transplantation and upon the medical published data.

 

References

Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between

and 2013. Lancet. 2015;386(10003):1546–55.

Clemente MG, Vajro P. An update on the strategies used for the treatment of chronic hepatitis B in children. Expert Rev Gastroenterol Hepatol. 2016;10(5):649–58.

Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang M-H, Thorne C, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4(6):466–76.

Polaris OC. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879–907.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Tushar AR, Karina Fatima Tithi